<DOC>
	<DOC>NCT02809248</DOC>
	<brief_summary>The aim of the study is to choose an optimal stent and to get further knowledge about the mechanisms of the engraftment of a stent. The occurrence of a hyperplasia of neointima can be minimized by application of a coated stent and a concurrent safety four weekly dual thrombocytes therapy</brief_summary>
	<brief_title>The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX- Stent Study)</brief_title>
	<detailed_description />
	<mesh_term>Constriction, Pathologic</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Coronary Restenosis</mesh_term>
	<criteria>male and female patients with a severe dysfunction of liver patient is planned a coronary stent implantation adults who are contractually capable and mentally able to understand and follow the instructions of the study personnel written informed consent prior to study participation younger than 18 years pregnancy and breastfeeding acute cardiac syndrome contraindication against an intracardiac catheter persons in dependence from the sponsor or working with the sponsor participation in a parallel interventional clinical trial patient has been committed to an institution by legal or regulatory order</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>LTX Study</keyword>
</DOC>